Redcare Pharmacy delivers a strong Q3, with Rx-driven revenue up 18% and adjusted EBITDA margin up 1.0% YoY to 3.4%. Company announcement - FT.com.

Financial Times Markets · 29 Oct, 05:30 UTC · Source

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.